Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice

Journal of General and Applied Microbiology

Volumn 51, Issue 2, 2005, Pages 83-92

  Martins, Flariano S ^a,b   Nardi, Regina M D ^a   Arantes, Rosa M E ^a   Rosa, Carlos A ^a   Neves, Maria J ^b   Nicoli, Jacques R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CENTRO DE DESENVOLVIMENTO DA TECNOLOGIA NUCLEAR   (Brazil)

Author keywords

Clostridium difficile; Germ free and conventional mice; Probiotics; Saccharomyces cerevisiae; Salmonella Typhimurium

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS ISOLATION; GASTROINTESTINAL INFECTION; GNOTOBIOTICS; HISTOPATHOLOGY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANIMAL; BACTERIAL COUNT; BACTERIAL INFECTION; CYTOCHEMISTRY; FECES; GASTROINTESTINAL DISEASE; GERMFREE ANIMAL; GROWTH, DEVELOPMENT AND AGING; INTESTINE; LIVER; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SALMONELLOSIS; SURVIVAL;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; FUNGI; INSECTA; MAMMALIA; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM;

ANIMALS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLONY COUNT, MICROBIAL; FECES; GASTROINTESTINAL DISEASES; GERM-FREE LIFE; HISTOCYTOCHEMISTRY; INTESTINES; LIVER; MICE; PROBIOTICS; SACCHAROMYCES CEREVISIAE; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SURVIVAL ANALYSIS;

EID: 21244487834     PISSN: 00221260     EISSN: None     Source Type: Journal    
DOI: 10.2323/jgam.51.83     Document Type: Article

References (48)

1. Barnett, J. A., Payne, R. W., and Yarrow, D. (1990) Yeast: Characteristics and Identification, University Press Cambridge, Cambridge.
2. Bartlett, J. G. (1992) Antibiotic-associated diarrhea. Clin. Infect. Dis., 15, 573-581.
3. Bléhaut, H., Massot, J., Elmer, G. W., and Levy, R. H. (1989) Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm. Drug Dispos., 10, 353-364.
4. Born, P., Lersch, C., Zimmerhackl, B., and Claassen, M. (1993) The Saccharomyces boulardii therapy of HIV-associated diarrhea (letter). Dtsch. Med. Wochenschr., 118, 765.
5. Brandão, R. L., Castro, I. M., Bambirra, E. A., Amaral, S. C., Fietto, L. G., Tropia, M. J. M., Neves, M. J., Santos, R. G., Gomes, N. C. M., and Nicoli, J. R. (1998) Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl. Environ. Microbiol., 64, 564-568.
6. Brugier, S. and Patte, F. (1975) Antagonisme in vitro entre l'ultra-levure et différents germes bactériens. Med. Paris, 45, 61-66.
7. Buts, J. P., Bernasconi, P., Vaerman, J. P., and Dive, C. (1990) Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig. Dis. Sci., 35, 251-256.
8. Buts, J. P., Bernasconi, P., Van Craynest, M. P., Maldague, P., and De Meyer, R. (1986) Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr. Res., 20, 192-196.
9. Caetano, J. A. M., Paramés, M. T., Babo, M. J., Santos, A., Ferreira, A. B., Freitas, A. A., Coelho, M. R. C., and Mateus, A. M. (1986) Immunopharmacological effects of Saccharomyces boulardii in healthy volunteers. Int. J. Immunopharmacol., 8, 245-259.
10. Castagliuolo, I., Lamont, J. T., Nikulasson, S. T., and Pothoulakis, C. (1996) Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect. Immun., 64, 5225-5232.
11. Castagliuolo, I., Riegler, M. F., Valenick, L., Lamont, J. T., and Pothoulakis, C. (1999) Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun., 67, 302-307.
12. Castex, F., Corthier, G., Jouvert, S., Elmer, G. W., Lucas, F., and Bastide, M. (1990) Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: A scanning electron microscopic and microbiological study. J. Gen. Microbiol., 136: 1085-1089.
13. Chia, J. K. S., Chan, S. M., and Goldstein, H. (1995) Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea. Clin. Infect. Dis., 20, 1581.
14. Ciriello, C. J. and Lachance, M. A. (2001) YEASTCOMPARE, University of Western Ontario, London, ON, Canada.
15. Corthier, G., Dubos, F., and Ducluzeau, R. (1986) Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Can. J. Microbiol., 32, 894-896.
16. Corthier, G., Lucas, F., Jouvert, S., and Castex, F. (1992) Effect of oral Saccharomyces boulardii treatment on the activity of Clostridium difficile toxins in mouse digestive tract. Toxicon, 30, 1583-1589.
17. - secretion in T84 cells. Dig. Dis. Sci., 44, 2359-2368.
18. Czerucka, D. and Rampal, P. (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect., 4, 733-739.
19. Czerucka, D., Dahan, S., Mograbi, B., Rossi, B., and Rampal, P. (2000) Saccharomyces boulardii preserves the barrier function and modulates the transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect. Immun., 68, 5998-6004.
20. Czerucka, D., Nano, J. L., Bernasconi, P., and Rampal, P. (1989) Effect of Saccharomyces boulardii on cholera toxin-induced cAMP levels in rat epithelial intestinal cell lines. Gastroenterol. Clin. Biol., 3, 383-384.
21. Czerucka, D., Nano, J. L., Bernasconi, P., and Rampal, P. (1991) Response of the IRD intestinal epithelial cell line to Clostridium difficile toxins A and B in rats. Effect of Saccharomyces boulardii. Gastroenterol. Clin. Biol., 15, 22-27.
22. Czerucka, D., Roux, I., and Rampal, P. (1994) Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells. Gastroenterology, 106, 65-72.
23. Elmer, G. W. and Corthier, G. (1991) Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice. Can. J. Microbiol., 37, 315-317.
24. Elmer, G. W., Mcfarland, L. V., Surawicz, C. M., Danko, L., and Greenberg, R. N. (1999) Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment. Pharmacol. Ther., 13, 1663-1668.
25. Gedek, B. R. (1999) Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses, 42, 261-264.
26. Izadnia, F., Wong, C. T., and Kocoshis, S. A. (1998) Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat. Dig. Dis. Sci., 43, 2055-2060.
27. Jahn, H. U., Ullrich, R., Schneider, T., Liehr, R. M., Schieferdecker, H. L., Holst, H., and Zeitz, M. (1996) Immunological and tropical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers. Digestion, 57, 95-104.
28. Kimmey, M. B., Elmer, G. W., Surawicz, C. M., and Mcfarland, L. V. (1990) Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Dig. Dis. Sci., 35, 897-901.
29. Kovacs, D. J. and Berk, T. (2000) Recurrent Clostridium difficile-associated diarrhea and colitis treated with Saccharomyces cerevisiae (baker's yeast) in combination with antibiotic therapy: A case report. J. Am. Board Farm. Pract., 13, 138-140.
30. Kurtzman, C. P. and Fell, J. W. (1998) The Yeasts: A Taxonomic Study, 4th ed., Elsevier Science Publishers, Amsterdam.
31. McFarland, L. V. and Bernasconi, P. (1993) Saccharomyces boulardii: A review of an innovative biotherapeutic agent. Microb. Ecol. Health Dis., 6, 157-171.
32. McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Fekety, R., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K. E., Cox, J. L., and Noorani, Z. (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J. Am. Med. Assoc., 271, 1913-1918.
33. McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K. E., and Cox, J. L. (1995) Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol., 90, 439-448.
34. Morais, P. B., Hagler, A. N., Rosa, C. A., Mendonça-Hagler, L. C., and Klaczko, L. B. (1992) Yeasts associated with Drosophila in tropical forests of Rio de Janeiro, Brazil. Can. J. Microbiol., 38, 1150-1155.
35. National Research Council (1996) Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington.
36. Neves, M. J., Etchebehere, L., Brandão, R. L., Castro, I. M., Lima, M. E., and Nicoli, J. R. (2002) Partial characterization of cholera toxin binding on membranes of Saccharomyces boulardii. Microecol. Ther., 29, 185-190.
37. Pleasants, J. R. (1974) Gnotobiotics. In Handbook of Laboratory Animal Science, ed. by Melby, E. C., Jr. and Altmann, N. H., CRC Press, Cleveland, pp. 119-174.
38. Pothoulakis, C., Kelly, C. P., Joshi, M. A., Gao, N., O'Keane, C. J., Castagliuolo, I., and Lamont, J. T. (1993) Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology, 104, 1108-1115.
39. Qamar, A., Aboudola, S., Warny, M., Michetti, P., Pothoulakis, C., Lamont, J. T., and Kelly, C. P. (2001) Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect. Immun., 69, 2762-2765.
40. Rodrigues, A. C., Cara, D. C., Fretez, S. H. G. G., Cunha, F. Q., Vieira, E. C., Nicoli, J. R., and Vieira, L. Q. (2000) Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J. Appl. Microbiol., 89, 404-414.
41. Saint-Marc, T., Rossello-Prats, L., and Touraine, J. L. (1991) Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS (letter). Ann. Med. Intern., 142, 64-65.
42. Scarpignato, C. and Rampal, P. (1995) Prevention and treatment of traveler's diarrhea: A clinical pharmacological approach. Chemotherapy, 41, 48-81.
43. Schellenberg, D., Bonington, A., Champion, M., Lancaster, R., Webb, S., and Main, J. (1994) Treatment of Clostridium difficile diarrhea with brewer's yeast. Lancet, 343, 171-172.
44. Surawicz, C. M. (2003) Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract. Res. Clin. Gastroenterol., 17, 775-783.
45. Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., and Van Bell, G. (1989a) Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii. Gastroenterology, 96, 981-988.
46. Surawicz, C. M., Mcfarland, L. V., Elmer, G., and Chinn, J. (1989b) Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am. J. Gastroenterol., 84, 1285-1287.
47. Surawicz, C. M., McFarland, L. V., Greenberg, R. N., Rubin, M., Fekety, R., Mulligan, M. E., Garcia, R. J., Brandmarker, S., Bowen, K., Borjal, D., and Elmer, G. W. (2000) The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis., 31, 1012-1017.
48. Yarrow, D. (1998) Methods for the isolation, maintenance and identification of yeasts. In The Yeasts, A Taxonomic Study, 4th ed., ed. by Kurtzman, C. P. and Fell, J. W., Elsevier, Amsterdam, pp. 77-100.